麝香四黄汤治疗出血性中风急性期痰热腑实证的临床研究

《麝香四黄汤治疗出血性中风急性期痰热腑实证的临床研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、提要目的：观察麝香四黄汤治疗出血性中风急性期痰热腑实证的临床疗效，并探讨其作用机理，旨在寻找治疗出血性中风急性期的理想方药，减少病残率，提高患者生存质量。方法：根据纳入病例标准将60例出血性中风急性期痰热腑实证患者随机分为治疗组30例与对照组30例。在常规西药治疗基础上，治疗组连续5天口服或鼻饲麝香四黄汤，对照组连续5天服用牛黄清心丸。两组于治疗14天后进行疗效评价。结果：治疗后两组在中医证候积分、神经功能缺损程度积分、日常生活能力观察项目方面较治疗前均有明显改善（P＜0.05）,且治疗组优于对照组（P＜0.01），提示两组治疗对出血性中风急性期痰热腑

2、实证均有效，而治疗组优于对照组。结论：麝香四黄汤具有化痰开窍、通腑泄热的作用，与常规西药治疗有协同作用，可提高疗效和患者的生存质量。提示麝香四黄汤中西结合治疗可作为治疗出血性中风急性期的理想方案。关键词麝香四黄汤；出血性中风急性期；痰热腑实证；临床研究TheClinicalResearchontheTreatmentofPhlegm-HeatAccumulationofAcuteHemorrhagicApoplexybyShexiang-SihuangDecoctionSpeciality：TheStudyofNervousSystemDiseaseo

3、fTCMAuthor：TangWenjingTutor：Pro.ZhangLunzhongAbstractObjective：TheautherinitiallydiscussesthepathologyandtherapyforacutehemorrhagicapoplexybyShexiang-sihuangDecoctiontostudyfromtheclinicalanglethetherapiceffectofhemorrhagicapoplexyandfindthebestprojectofacutehemorrhagicapoplexy,

4、decreasemortalityandimprovelifequalityofpatients.Methods：Atotalof60patientswithacutehemorrhagicapoplexyweredividedrandomlyintotwogroups.Thetreatmentgroup(30cases)andthecontrolgroup(30cases).Inthewesternbasedonconventionaltreatment,thetreatmentgroupwereadoptedtraditionalChineseme

5、dicineShexiang-SihuangDecoctionoraladministration5days.ThecontrolgroupwereadoptedtraditionalChinesemedicineNiuhuang-QingxinPillsoraladministration5days.Twogroupsintreatmentfor14daysaftereffectassessment.Results：Thetreatmentgroupwasimprovedsignificantlycomparedtothecontrolgroupin

6、nervousfunctiondefect,dailyviability,psychosisafteracutehemorrhagicapoplexy,andtraditionalChinesemedicinesyndrome(P<0.05).TheresultsshowShexiang-SihuangDecoctionimprovetherecoveryofpatients.Conclusion：ThepaperindicatedthatShexiang-SihuangDecoctionTCMwithmodernmedicinewerebettere

7、ffectiveandsafeinthetreatmentofacutehemorrhagicapoplexy.Andindicatedthatthiswasabesttreatmentmethodofacutehemorrhagicapoplexy.KeywordsShexiang-SihuangDecoction;Acutehemorrhagicapoplexy;Phlegm-heataccumulation;clinicalresearch目录引言..................................................

8、...............................................